Theravance Biopharma, Inc. (TBPH)
17.01
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
17.00
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma Shareholders Equity (Quarterly) : 289.70M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 289.70M |
| March 31, 2026 | 290.59M |
| December 31, 2025 | 296.72M |
| September 30, 2025 | 232.68M |
| June 30, 2025 | 224.85M |
| March 31, 2025 | 165.98M |
| December 31, 2024 | 175.54M |
| September 30, 2024 | 185.65M |
| June 30, 2024 | 193.69M |
| March 31, 2024 | 204.87M |
| December 31, 2023 | 213.00M |
| September 30, 2023 | 246.13M |
| June 30, 2023 | 280.16M |
| March 31, 2023 | 370.56M |
| December 31, 2022 | 441.80M |
| September 30, 2022 | 480.58M |
| June 30, 2022 | -349.81M |
| March 31, 2022 | -351.45M |
| December 31, 2021 | -338.57M |
| September 30, 2021 | -323.59M |
| June 30, 2021 | -300.37M |
| March 31, 2021 | -373.22M |
| December 31, 2020 | -303.75M |
| September 30, 2020 | -261.54M |
| June 30, 2020 | -202.34M |
| Date | Value |
|---|---|
| March 31, 2020 | -157.94M |
| December 31, 2019 | -223.84M |
| September 30, 2019 | -182.80M |
| June 30, 2019 | -137.22M |
| March 31, 2019 | -113.25M |
| December 31, 2018 | -51.59M |
| September 30, 2018 | -13.44M |
| June 30, 2018 | 34.39M |
| March 31, 2018 | 63.41M |
| December 31, 2017 | 115.18M |
| September 30, 2017 | 184.12M |
| June 30, 2017 | 241.13M |
| March 31, 2017 | 293.95M |
| December 31, 2016 | 350.23M |
| September 30, 2016 | 297.87M |
| June 30, 2016 | 321.58M |
| March 31, 2016 | 238.54M |
| December 31, 2015 | 243.06M |
| September 30, 2015 | 222.54M |
| June 30, 2015 | 257.67M |
| March 31, 2015 | 289.12M |
| December 31, 2014 | 289.79M |
| September 30, 2014 | 339.82M |
| June 30, 2014 | 384.76M |
| March 31, 2014 | -17.92M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zymeworks, Inc. | 80.37M |
| Viatris, Inc. | 14.26B |
| Ocular Therapeutix, Inc. | 520.04M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 469.77M |
| Total Liabilities (Quarterly) | 180.06M |
| Debt to Equity Ratio | 0.2463 |
| Current Ratio | 13.54 |
| Net Debt Paydown Yield | 0.18% |